184 related articles for article (PubMed ID: 27918115)
1. An Amphiphilic Ruthenium Polymetallodrug for Combined Photodynamic Therapy and Photochemotherapy In Vivo.
Sun W; Li S; Häupler B; Liu J; Jin S; Steffen W; Schubert US; Butt HJ; Liang XJ; Wu S
Adv Mater; 2017 Feb; 29(6):. PubMed ID: 27918115
[TBL] [Abstract][Full Text] [Related]
2. Photoresponsive ruthenium-containing polymers: potential polymeric metallodrugs for anticancer phototherapy.
Sun W; Zeng X; Wu S
Dalton Trans; 2018 Jan; 47(2):283-286. PubMed ID: 29177301
[TBL] [Abstract][Full Text] [Related]
3. Ruthenium-Containing Block Copolymer Assemblies: Red-Light-Responsive Metallopolymers with Tunable Nanostructures for Enhanced Cellular Uptake and Anticancer Phototherapy.
Sun W; Parowatkin M; Steffen W; Butt HJ; Mailänder V; Wu S
Adv Healthc Mater; 2016 Feb; 5(4):467-73. PubMed ID: 26680371
[TBL] [Abstract][Full Text] [Related]
4. Fighting against Drug-Resistant Tumors using a Dual-Responsive Pt(IV)/Ru(II) Bimetallic Polymer.
Zeng X; Wang Y; Han J; Sun W; Butt HJ; Liang XJ; Wu S
Adv Mater; 2020 Oct; 32(43):e2004766. PubMed ID: 32964540
[TBL] [Abstract][Full Text] [Related]
5. A Ru-anthraquinone dyad with triple functions of PACT, photoredox catalysis and PDT upon red light irradiation.
Zhang C; Guo X; Da X; Wang Z; Wang X; Zhou Q
Dalton Trans; 2021 Aug; 50(31):10845-10852. PubMed ID: 34296720
[TBL] [Abstract][Full Text] [Related]
6. A Near-Infrared Light-Activated Photocage Based on a Ruthenium Complex for Cancer Phototherapy.
He G; He M; Wang R; Li X; Hu H; Wang D; Wang Z; Lu Y; Xu N; Du J; Fan J; Peng X; Sun W
Angew Chem Int Ed Engl; 2023 Jun; 62(24):e202218768. PubMed ID: 36890113
[TBL] [Abstract][Full Text] [Related]
7. Red-Light-Responsive Polypeptoid Nanoassemblies Containing a Ruthenium(II) Polypyridyl Complex with Synergistically Enhanced Drug Release and ROS Generation for Anticancer Phototherapy.
Ma Y; Zhang Z; Sun F; Mesdom P; Ji X; Burckel P; Gasser G; Li MH
Biomacromolecules; 2023 Dec; 24(12):5940-5950. PubMed ID: 38033171
[TBL] [Abstract][Full Text] [Related]
8. Critical Overview of the Use of Ru(II) Polypyridyl Complexes as Photosensitizers in One-Photon and Two-Photon Photodynamic Therapy.
Heinemann F; Karges J; Gasser G
Acc Chem Res; 2017 Nov; 50(11):2727-2736. PubMed ID: 29058879
[TBL] [Abstract][Full Text] [Related]
9. Strained ruthenium complexes are potent light-activated anticancer agents.
Howerton BS; Heidary DK; Glazer EC
J Am Chem Soc; 2012 May; 134(20):8324-7. PubMed ID: 22553960
[TBL] [Abstract][Full Text] [Related]
10. A self-assembled Ru-Pt metallacage as a lysosome-targeting photosensitizer for 2-photon photodynamic therapy.
Zhou Z; Liu J; Huang J; Rees TW; Wang Y; Wang H; Li X; Chao H; Stang PJ
Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20296-20302. PubMed ID: 31548389
[TBL] [Abstract][Full Text] [Related]
11. Development of Ruthenium Nanophotocages with Red or Near-Infrared Light-Responsiveness.
Zhang Z; He M; Wang R; Fan J; Peng X; Sun W
Chembiochem; 2023 Dec; 24(24):e202300606. PubMed ID: 37837285
[TBL] [Abstract][Full Text] [Related]
12. Photochemical property of two Ru(II) compounds based on 5-(2-pyrazinyl)tetrazole for cancer phototherapy by changing auxiliary ligand.
Yang J; Xu Y; Jiang M; Zou D; Yang G; Shen L; Zou J
J Inorg Biochem; 2019 Apr; 193():124-129. PubMed ID: 30711558
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of action of Ru(ii) polypyridyl complexes in living cells upon light irradiation.
Jakubaszek M; Goud B; Ferrari S; Gasser G
Chem Commun (Camb); 2018 Nov; 54(93):13040-13059. PubMed ID: 30398487
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Medicinal Potential of Two Ruthenium(II) Polypyridine Complexes as One- and Two-Photon Photodynamic Therapy Photosensitizers.
Hess J; Huang H; Kaiser A; Pierroz V; Blacque O; Chao H; Gasser G
Chemistry; 2017 Jul; 23(41):9888-9896. PubMed ID: 28509422
[TBL] [Abstract][Full Text] [Related]
15. Amphiphilic copolymer coated upconversion nanoparticles for near-infrared light-triggered dual anticancer treatment.
Yang S; Li N; Liu Z; Sha W; Chen D; Xu Q; Lu J
Nanoscale; 2014 Dec; 6(24):14903-10. PubMed ID: 25362857
[TBL] [Abstract][Full Text] [Related]
16. Photoactivated full-API nanodrug (FAND): harnessing transition metal complexes and MTH1 inhibitor for enhanced DNA damage in cancer cells.
Zhu H; Cui M; Tang Q; Zhao H; Zhang P; Zeng S; Li W; Zhou Q; Zhang J; Chen Y
Biomater Sci; 2024 Jun; 12(12):3154-3162. PubMed ID: 38687170
[TBL] [Abstract][Full Text] [Related]
17. Nanostructured polymer assemblies stabilize photoactivatable anticancer ruthenium complexes under physiological conditions.
Chen M; Sun W; Kretzschmann A; Butt HJ; Wu S
J Inorg Biochem; 2020 Jun; 207():111052. PubMed ID: 32187562
[TBL] [Abstract][Full Text] [Related]
18. Novel Ru(II) complexes with multiple anticancer photoreactivity: ligand exchange, photoredox catalysis, reactive oxygen generation and endoperoxide formation.
Dao A; Wu H; Wei S; Huang H
Phys Chem Chem Phys; 2023 Jul; 25(29):20001-20008. PubMed ID: 37461395
[TBL] [Abstract][Full Text] [Related]
19. Discovery of immunogenic cell death-inducing ruthenium-based photosensitizers for anticancer photodynamic therapy.
Konda P; Lifshits LM; Roque JA; Cole HD; Cameron CG; McFarland SA; Gujar S
Oncoimmunology; 2020 Dec; 10(1):1863626. PubMed ID: 33457082
[TBL] [Abstract][Full Text] [Related]
20. Fusion of photodynamic therapy and photoactivated chemotherapy: a novel Ru(II) arene complex with dual activities of photobinding and photocleavage toward DNA.
Chen Y; Lei W; Jiang G; Hou Y; Li C; Zhang B; Zhou Q; Wang X
Dalton Trans; 2014 Nov; 43(41):15375-84. PubMed ID: 25188424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
